Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-May-23 6:19 PM View:  | Akebia Therapeutics, Inc. (AKBA) | 16-May-23 | Sale | 63,567 | $1.07 | $67,889.60 | (12%) 510.05K to 446.48K | |
| 03-Mar-23 8:00 AM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Mar-23 | Sale | 7,210 | $0.88 | $6,326.77 | (1%) 517.26K to 510.05K | |
| 01-Mar-23 4:05 PM View: | Akebia Therapeutics, Inc. (AKBA) | 27-Feb-23 | Sale | 7,539 | $0.81 | $6,130.71 | (1%) 524.8K to 517.26K | |
| 02-Feb-23 4:14 PM View: | Akebia Therapeutics, Inc. (AKBA) | 31-Jan-23 | Grant | 196,200 | -- | -- | 60% 328.6K to 524.8K | |
| 10-Jun-22 8:11 AM View: | Akebia Therapeutics, Inc. (AKBA) | 08-Jun-22 | Grant | 200,000 | -- | -- | 156% 128.6K to 328.6K | |
| 02-Mar-22 9:09 PM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Mar-22 | Sale | 803 | $2.17 | $1,743.07 | (< 1%) 129.4K to 128.6K | |
| 02-Mar-22 9:09 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-22 | Grant | 60,000 | -- | -- | 78% 76.8K to 136.8K | |
| 02-Mar-22 9:09 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-22 | Sale | 7,400 | $2.15 | $15,945.50 | (5%) 136.8K to 129.4K | |
| 01-Apr-21 8:34 PM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Apr-21 | Market Sale | 790 | $3.40 | $2,686.00 | (1%) 77.59K to 76.8K | < 1% |
| 18-Mar-21 7:19 PM View: | Akebia Therapeutics, Inc. (AKBA) | 16-Mar-21 | Grant | 7,592 | -- | -- | 11% 70.0K to 77.59K | |
| 02-Mar-21 4:05 PM View: | Akebia Therapeutics, Inc. (AKBA) | 26-Feb-21 | Grant | 70,000 | -- | -- | 100% 0 to 70.0K |